More about science

Acquired Thrombotic Thrombocytopenic Purpura (ATTP)

Asthma

Atopic Dermatitis

Cardiovascular

Chronic Obstructive Pulmonary Disease

Diabetes

Eosinophilic Esophagitis

Latest trends

Explore the most popular scientific articles and videos among Campus Sanofi users

See everything

EMPOWER Study in Saudi Arabia

Key highlights from the EMPOWER Study in Saudi Arabia

Learn More

Chronic Obstructive Pulmonary Disease

(COPD): Disease Burden and Heterogeneity

Learn More

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD): Disease Burden and Heterogeneity

Learn More

EOE Pediatric - Unmasking the Hidden Symptoms

Learn More

Airway Hyperresponsiveness<br/>in Asthma

Asthma
cutting-edge-science

Airway Hyperresponsiveness
in Asthma

Learn More

Atopic Dermatitis Pathophysiology: Breaking Down the Barrier

Learn More

Importance of assessing key disease domains in EOE

Learn More

Daily Burden of CRSwNP

Learn More

See everything

Events

Stay up to date and register for the latest events and view webinar recordings

See everything

Dia-Tour: Navigating New Destinations in Diabetes Management

Learn More

Fabry Monitoring Matters Webinar Series

Learn More

Neurological Disorders

Sir Robin Murray updates us on Schizophrenia and it’s treatments

Updates on the Causes and Treatments of Schizophrenia

Learn More

World Diabetes Day

Dr. Hussein Elbadawi talks about Hypoglycemia and how is it classified.

Learn More

Safe & Smart - Dr. Salah

Dr. Salah gives us the updated guidelines on Sulphonylureas and Cardiovascular safety

Learn More

Safe & Smart - Dr. Nabil

Dr. Nabil talks about Sulphonylureas within treatment landscape in Ramadan

Learn More

Safe & Smart - Dr. Khudhair

Dr. Khudhair discusses Carolina: Cardiovascular outcomes

Learn More

Safe & Smart - Dr. Kalra

Dr. Kalra discusses Quinary Prevention in Diabetes Care

Learn More

See everything

Support for your patients

Discover the selection of support materials for patients from different therapeutic areas

See everything

Are You Ready for 146? Achieving Optimal LDL-C Levels

Learn More

Are You Ready for 556? Achieving Critical LDL-C Targets

Learn More

Exploring the 556/146 Concept: Insights from Leading Experts

Learn More

Understanding the 556/146 Concept: Insights from Leading Experts

Learn More

556/146 for Lipid Management after ACS

Learn More

Dyslipidemia

Why Praluent is the Optimal Choice for Post-ACS Patients?

Explore the compelling reasons why Praluent should be your first choice for patients with recent acute coronary syndrome who need to achieve their LDL-C goals. This informative video provides in-depth clinical insights and evidence, detailing how Praluent’s unique mechanism of action and proven efficacy can significantly improve patient outcomes. The video also covers tips on the 3 main factors: efficacy, safety, and administration to help you to integrate Praluent into your treatment plans. Enhance patient outcomes and elevate your practice with Praluent.

Learn More